Literature DB >> 20870300

The minor binding pocket: a major player in 7TM receptor activation.

Mette M Rosenkilde1, Tau Benned-Jensen, Thomas M Frimurer, Thue W Schwartz.   

Abstract

From the deep part of the main ligand-binding crevice, a minor, often shallower pocket extends between the extracellular ends of transmembrane domains (TM)-I, II, III and VII of 7TM receptors. This minor binding pocket is defined by a highly conserved kink in TM-II that is induced by a proline residue located in one of two adjacent positions. Here we argue that this minor binding pocket is important for receptor activation. Functional coupling of the receptors seems to be mediated through the hydrogen bond network located between the intracellular segments of these TMs, with the allosteric interface between TM-II and TM-VII being of particular significance. Importantly, the minor binding pocket, especially the proline-kink in TM-II, is involved in G protein versus arrestin pathway-biased signaling, for example in the angiotensin AT1 system. Consequently, this pocket could be specifically targeted in the development of functionally biased drugs.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20870300     DOI: 10.1016/j.tips.2010.08.006

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  41 in total

1.  Identification of Distinct Conformations of the Angiotensin-II Type 1 Receptor Associated with the Gq/11 Protein Pathway and the β-Arrestin Pathway Using Molecular Dynamics Simulations.

Authors:  Jérôme Cabana; Brian Holleran; Richard Leduc; Emanuel Escher; Gaétan Guillemette; Pierre Lavigne
Journal:  J Biol Chem       Date:  2015-05-01       Impact factor: 5.157

2.  Identification of essential cannabinoid-binding domains: structural insights into early dynamic events in receptor activation.

Authors:  Joong-Youn Shim; Alexander C Bertalovitz; Debra A Kendall
Journal:  J Biol Chem       Date:  2011-07-27       Impact factor: 5.157

3.  Allosteric and orthosteric sites in CC chemokine receptor (CCR5), a chimeric receptor approach.

Authors:  Stefanie Thiele; Anne Steen; Pia C Jensen; Jacek Mokrosinski; Thomas M Frimurer; Mette M Rosenkilde
Journal:  J Biol Chem       Date:  2011-08-30       Impact factor: 5.157

Review 4.  Lifting the lid on GPCRs: the role of extracellular loops.

Authors:  M Wheatley; D Wootten; M T Conner; J Simms; R Kendrick; R T Logan; D R Poyner; J Barwell
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

5.  Identification and functional comparison of seven-transmembrane G-protein-coupled BILF1 receptors in recently discovered nonhuman primate lymphocryptoviruses.

Authors:  Katja Spiess; Suzan Fares; Alexander H Sparre-Ulrich; Ellen Hilgenberg; Michael A Jarvis; Bernhard Ehlers; Mette M Rosenkilde
Journal:  J Virol       Date:  2014-12-10       Impact factor: 5.103

Review 6.  New paradigms in chemokine receptor signal transduction: Moving beyond the two-site model.

Authors:  Andrew B Kleist; Anthony E Getschman; Joshua J Ziarek; Amanda M Nevins; Pierre-Arnaud Gauthier; Andy Chevigné; Martyna Szpakowska; Brian F Volkman
Journal:  Biochem Pharmacol       Date:  2016-04-19       Impact factor: 5.858

7.  Reversed binding of a small molecule ligand in homologous chemokine receptors - differential role of extracellular loop 2.

Authors:  P C Jensen; S Thiele; A Steen; A Elder; R Kolbeck; S Ghosh; T M Frimurer; M M Rosenkilde
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

Review 8.  Calcitonin and calcitonin receptor-like receptors: common themes with family B GPCRs?

Authors:  James Barwell; Joseph J Gingell; Harriet A Watkins; Julia K Archbold; David R Poyner; Debbie L Hay
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

9.  Structure-Activity Analysis of Biased Agonism at the Human Adenosine A3 Receptor.

Authors:  Jo-Anne Baltos; Silvia Paoletta; Anh T N Nguyen; Karen J Gregory; Dilip K Tosh; Arthur Christopoulos; Kenneth A Jacobson; Lauren T May
Journal:  Mol Pharmacol       Date:  2016-05-02       Impact factor: 4.436

10.  Determination of the binding mode for the cyclopentapeptide CXCR4 antagonist FC131 using a dual approach of ligand modifications and receptor mutagenesis.

Authors:  S Thiele; J Mungalpara; A Steen; M M Rosenkilde; J Våbenø
Journal:  Br J Pharmacol       Date:  2014-12       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.